Symbols / HIMS
HIMS Chart
About
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 3.52B |
| Enterprise Value | 4.02B | Income | 133.79M | Sales | 2.21B |
| Book/sh | 2.55 | Cash/sh | 2.77 | Dividend Yield | — |
| Payout | 0.00% | Employees | 1637 | IPO | — |
| P/E | 29.17 | Forward P/E | 10.84 | PEG | — |
| P/S | 1.59 | P/B | 6.05 | P/C | — |
| EV/EBITDA | 23.91 | EV/Sales | 1.82 | Quick Ratio | 1.49 |
| Current Ratio | 1.88 | Debt/Eq | 192.44 | LT Debt/Eq | — |
| EPS (ttm) | 0.51 | EPS next Y | 1.43 | EPS Growth | -80.30% |
| Revenue Growth | 49.20% | Earnings | 2026-05-04 | ROA | 5.54% |
| ROE | 26.21% | ROIC | — | Gross Margin | 75.01% |
| Oper. Margin | 1.97% | Profit Margin | 6.05% | Shs Outstand | 219.27M |
| Shs Float | 208.00M | Short Float | 41.71% | Short Ratio | 4.62 |
| Short Interest | — | 52W High | 70.43 | 52W Low | 13.74 |
| Beta | 2.47 | Avg Volume | 20.68M | Volume | 61.62M |
| Target Price | $23.69 | Recom | Hold | Prev Close | $15.51 |
| Price | $15.46 | Change | -0.32% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$20.19
Mean price target
2. Current target
$15.46
Latest analyst target
3. DCF / Fair value
$16.01
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.46
Low
$12.50
High
$30.00
Mean
$20.19
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-24 | main | Leerink Partners | Market Perform → Market Perform | $18 |
| 2026-02-24 | down | BTIG | Buy → Neutral | — |
| 2026-02-24 | main | Citigroup | Sell → Sell | $13 |
| 2026-02-24 | main | TD Cowen | Hold → Hold | $17 |
| 2026-02-24 | reit | Truist Securities | Hold → Hold | $18 |
| 2026-02-24 | main | Evercore ISI Group | In-Line → In-Line | $24 |
| 2026-02-09 | main | TD Cowen | Hold → Hold | $20 |
| 2026-02-09 | main | Citigroup | Sell → Sell | $17 |
| 2026-02-09 | main | B of A Securities | Underperform → Underperform | $21 |
| 2026-02-02 | main | BTIG | Buy → Buy | $60 |
| 2026-01-12 | init | Evercore ISI Group | — → In-Line | $33 |
| 2025-12-09 | init | Barclays | — → Overweight | $48 |
| 2025-11-04 | main | B of A Securities | Underperform → Underperform | $32 |
| 2025-11-04 | reit | BTIG | Buy → Buy | $85 |
| 2025-10-21 | init | Keybanc | — → Sector Weight | — |
| 2025-09-12 | main | Canaccord Genuity | Buy → Buy | $68 |
| 2025-08-18 | main | Truist Securities | Hold → Hold | $37 |
| 2025-08-05 | reit | Needham | Hold → Hold | — |
| 2025-07-17 | main | Truist Securities | Hold → Hold | $48 |
| 2025-06-11 | reit | Morgan Stanley | Equal-Weight → Equal-Weight | $40 |
- Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - Hims Investor Relations Mon, 23 Feb 2026 21
- Earnings live: Workday stock plunges amid AI disruption concerns, Lucid falls on mixed quarter, HP tumbles - Yahoo Finance ue, 24 Feb 2026 23
- Stocks making the biggest moves premarket: AMD, Home Depot, Hims & Hers Health, Diamondback Energy and more - CNBC ue, 24 Feb 2026 12
- Earnings live: Hims & Hers stock slides, Domino's rises as investors await crucial update from Nvidia - Yahoo Finance Mon, 23 Feb 2026 21
- Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside - MarketBeat Sat, 21 Feb 2026 15
- Hims & Hers Stock Slips Despite Q4 Earnings Beat, Margins Contract - Zacks Investment Research ue, 24 Feb 2026 16
- Hims & Hers Health Fourth-Quarter Sales Rise, Gives Soft First-Quarter Guidance - WSJ Mon, 23 Feb 2026 23
- Hims & Hers Health Stock (HIMS) Opinions on Q4 Earnings Release - Quiver Quantitative ue, 24 Feb 2026 14
- Stock Movers: Keurig, Planet Fitness, Hims - Bloomberg ue, 24 Feb 2026 14
- HIMS Stock Plummets After Wall Street Downgrade, Price Target Cuts Following 'Disappointing' Q4 Report - Stocktwits ue, 24 Feb 2026 18
- These Stocks Are Today’s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More - Barron's ue, 24 Feb 2026 21
- Hims & Hers Health: Don't Get Lost In The Weeds (NYSE:HIMS) - Seeking Alpha ue, 24 Feb 2026 21
- Hims & Hers Health After The GLP-1 Collapse - Seeking Alpha ue, 24 Feb 2026 13
- Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform - Hims Investor Relations hu, 19 Feb 2026 11
- Truist cuts Hims and Hers stock price target on quarterly ramp concerns - Investing.com ue, 24 Feb 2026 15
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 5262 | 139108.0 | — | Sale at price 26.44 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-02-03 00:00:00 | D |
| 1 | 5262 | 26363.0 | — | Conversion of Exercise of derivative security at price 5.01 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-02-03 00:00:00 | D |
| 2 | 9067 | 275114.0 | — | Sale at price 30.34 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-20 00:00:00 | D |
| 3 | 9067 | 56836.0 | — | Conversion of Exercise of derivative security at price 5.01 - 11.53 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-20 00:00:00 | D |
| 4 | 9070 | 306453.0 | — | Sale at price 33.79 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-05 00:00:00 | D |
| 5 | 5986 | 54818.0 | — | Conversion of Exercise of derivative security at price 5.01 - 11.53 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-05 00:00:00 | D |
| 6 | 23090 | 824710.0 | — | Sale at price 35.72 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2025-12-22 00:00:00 | D |
| 7 | 8411 | 308768.0 | — | Sale at price 36.71 per share. | BECKLUND IRENE | Officer | — | 2025-12-17 00:00:00 | D |
| 8 | 7054 | 258952.0 | — | Sale at price 36.71 per share. | AUTOR DEBORAH M | Officer and Director | — | 2025-12-17 00:00:00 | D |
| 9 | 13750 | 504762.0 | — | Sale at price 36.71 per share. | CHI MICHAEL Y | Chief Operating Officer | — | 2025-12-17 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.00 | 0.03 |
| NormalizedEBITDA | 78.99M | -19.94M | -61.22M | -110.97M |
| TotalUnusualItems | 70.00K | 3.80M | ||
| TotalUnusualItemsExcludingGoodwill | 70.00K | 3.80M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | 126.04M | -23.55M | -65.68M | -107.66M |
| ReconciledDepreciation | 17.09M | 9.52M | 7.47M | 4.08M |
| ReconciledCostOfRevenue | 303.38M | 157.05M | 118.19M | 67.38M |
| EBITDA | 78.99M | -19.94M | -61.22M | -110.97M |
| EBIT | 61.90M | -29.45M | -68.70M | -115.04M |
| NetInterestIncome | 0.00 | |||
| InterestExpense | 0.00 | |||
| NormalizedIncome | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 126.04M | -23.55M | -65.68M | -107.66M |
| TotalExpenses | 1.41B | 901.45M | 595.61M | 386.92M |
| TotalOperatingIncomeAsReported | 61.90M | -29.45M | -68.70M | -115.04M |
| DilutedAverageShares | 236.81M | 209.34M | 204.52M | 186.78M |
| BasicAverageShares | 215.94M | 209.34M | 204.52M | 186.78M |
| DilutedEPS | 0.53 | -0.11 | -0.32 | -0.58 |
| BasicEPS | 0.58 | -0.11 | -0.32 | -0.58 |
| DilutedNIAvailtoComStockholders | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeCommonStockholders | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncome | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeIncludingNoncontrollingInterests | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeContinuousOperations | 126.04M | -23.55M | -65.68M | -107.66M |
| TaxProvision | -54.33M | 1.98M | -31.00K | -3.14M |
| PretaxIncome | 71.71M | -21.57M | -65.71M | -110.80M |
| OtherIncomeExpense | 9.81M | 7.88M | 2.99M | 4.25M |
| OtherNonOperatingIncomeExpenses | 9.81M | 7.88M | 2.99M | 4.25M |
| GainOnSaleOfSecurity | 70.00K | 3.80M | ||
| NetNonOperatingInterestIncomeExpense | 0.00 | |||
| InterestExpenseNonOperating | 0.00 | |||
| OperatingIncome | 61.90M | -29.45M | -68.70M | -115.04M |
| OperatingExpense | 1.11B | 744.40M | 477.42M | 319.54M |
| OtherOperatingExpenses | 185.80M | 119.86M | 77.40M | 47.59M |
| ResearchAndDevelopment | 78.82M | 48.23M | 29.24M | 22.38M |
| SellingGeneralAndAdministration | 846.61M | 576.32M | 370.78M | 249.56M |
| SellingAndMarketingExpense | 678.84M | 446.44M | 272.59M | 135.90M |
| GeneralAndAdministrativeExpense | 167.77M | 129.88M | 98.19M | 113.66M |
| OtherGandA | 167.77M | 129.88M | 98.19M | 113.66M |
| GrossProfit | 1.17B | 714.95M | 408.72M | 204.49M |
| CostOfRevenue | 303.38M | 157.05M | 118.19M | 67.38M |
| TotalRevenue | 1.48B | 872.00M | 526.92M | 271.88M |
| OperatingRevenue | 1.48B | 872.00M | 526.92M | 271.88M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 220.84M | 213.48M | 208.43M | 204.79M |
| ShareIssued | 220.84M | 213.48M | 208.43M | 204.79M |
| TotalDebt | 11.35M | 9.95M | 5.31M | 5.48M |
| TangibleBookValue | 320.58M | 214.57M | 179.02M | 197.85M |
| InvestedCapital | 476.72M | 344.03M | 311.74M | 334.62M |
| WorkingCapital | 174.46M | 176.59M | 168.65M | 190.68M |
| NetTangibleAssets | 320.58M | 214.57M | 179.02M | 197.85M |
| CapitalLeaseObligations | 11.35M | 9.95M | 5.31M | 5.48M |
| CommonStockEquity | 476.72M | 344.03M | 311.74M | 334.62M |
| TotalCapitalization | 476.72M | 344.03M | 311.74M | 334.62M |
| TotalEquityGrossMinorityInterest | 476.72M | 344.03M | 311.74M | 334.62M |
| StockholdersEquity | 476.72M | 344.03M | 311.74M | 334.62M |
| GainsLossesNotAffectingRetainedEarnings | -324.00K | -124.00K | -277.00K | -137.00K |
| OtherEquityAdjustments | -324.00K | -124.00K | -277.00K | -137.00K |
| RetainedEarnings | -242.14M | -368.18M | -344.63M | -278.95M |
| AdditionalPaidInCapital | 719.15M | 712.31M | 656.63M | 613.69M |
| CapitalStock | 22.00K | 21.00K | 21.00K | 20.00K |
| CommonStock | 22.00K | 21.00K | 21.00K | 20.00K |
| TotalLiabilitiesNetMinorityInterest | 230.82M | 97.16M | 54.60M | 85.97M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 9.46M | 8.69M | 6.66M | 6.75M |
| OtherNonCurrentLiabilities | 22.00K | 3.01M | 2.63M | |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| LongTermDebtAndCapitalLeaseObligation | 9.46M | 8.67M | 3.65M | 4.12M |
| LongTermCapitalLeaseObligation | 9.46M | 8.67M | 3.65M | 4.12M |
| CurrentLiabilities | 221.37M | 88.47M | 47.94M | 79.22M |
| CurrentDeferredLiabilities | 75.28M | 7.73M | 1.47M | 3.19M |
| CurrentDeferredRevenue | 75.28M | 7.73M | 1.47M | 3.19M |
| CurrentDebtAndCapitalLeaseObligation | 1.89M | 1.28M | 1.66M | 1.36M |
| CurrentCapitalLeaseObligation | 1.89M | 1.28M | 1.66M | 1.36M |
| PayablesAndAccruedExpenses | 144.19M | 79.45M | 44.81M | 74.67M |
| CurrentAccruedExpenses | 53.01M | 28.97M | 11.48M | 11.24M |
| Payables | 91.18M | 50.48M | 33.33M | 63.43M |
| OtherPayable | 7.41M | 42.83M | ||
| TotalTaxPayable | 2.01M | 963.00K | 954.00K | |
| AccountsPayable | 91.18M | 43.07M | 32.36M | 19.64M |
| TotalAssets | 707.54M | 441.19M | 366.34M | 420.58M |
| TotalNonCurrentAssets | 311.71M | 176.13M | 149.75M | 150.68M |
| OtherNonCurrentAssets | 1.00M | 947.00K | 889.00K | 8.80M |
| NonCurrentDeferredAssets | 61.60M | 0.00 | ||
| NonCurrentDeferredTaxesAssets | 61.60M | 0.00 | ||
| GoodwillAndOtherIntangibleAssets | 156.14M | 129.46M | 132.72M | 136.77M |
| OtherIntangibleAssets | 43.41M | 18.57M | 21.84M | 25.89M |
| Goodwill | 112.73M | 110.88M | 110.88M | 110.88M |
| NetPPE | 92.96M | 45.73M | 16.14M | 5.11M |
| AccumulatedDepreciation | -24.50M | -12.24M | -6.24M | |
| GrossPPE | 117.46M | 57.98M | 22.38M | 5.11M |
| Leases | 10.93M | 2.26M | 155.00K | |
| OtherProperties | 44.65M | 24.50M | 6.57M | 5.11M |
| MachineryFurnitureEquipment | 61.88M | 31.22M | 15.65M | |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 395.83M | 265.05M | 216.59M | 269.90M |
| OtherCurrentAssets | 8.90M | 4.20M | 1.78M | 890.00K |
| CurrentDeferredAssets | 0.00 | |||
| PrepaidAssets | 16.17M | 10.66M | 10.39M | 4.61M |
| Inventory | 64.43M | 22.46M | 21.56M | 13.56M |
| FinishedGoods | 35.08M | 15.22M | 16.48M | 10.43M |
| RawMaterials | 29.35M | 7.24M | 5.08M | 3.13M |
| Receivables | 6.08M | 6.75M | 3.23M | 3.58M |
| AccountsReceivable | 6.08M | 6.75M | 3.23M | 3.58M |
| CashCashEquivalentsAndShortTermInvestments | 300.25M | 220.98M | 179.62M | 247.27M |
| OtherShortTermInvestments | 79.67M | 124.32M | 132.85M | 175.49M |
| CashAndCashEquivalents | 220.58M | 96.66M | 46.77M | 71.78M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 198.33M | 46.99M | -33.78M | -39.42M |
| RepurchaseOfCapitalStock | -83.04M | -2.00M | 0.00 | -22.03M |
| RepaymentOfDebt | 0.00 | 0.00 | ||
| IssuanceOfDebt | 0.00 | 0.00 | 1.19M | |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 272.69M | |
| CapitalExpenditure | -52.75M | -26.49M | -7.25M | -5.01M |
| InterestPaidSupplementalData | 0.00 | 0.00 | ||
| IncomeTaxPaidSupplementalData | 7.92M | 1.11M | 636.00K | 338.00K |
| EndCashPosition | 221.44M | 97.52M | 47.63M | 72.64M |
| BeginningCashPosition | 97.52M | 47.63M | 72.64M | 28.35M |
| EffectOfExchangeRateChanges | -270.00K | -11.00K | -53.00K | -73.00K |
| ChangesInCash | 124.19M | 49.90M | -24.96M | 44.36M |
| FinancingCashFlow | -107.84M | -11.47M | -33.13M | 235.04M |
| CashFlowFromContinuingFinancingActivities | -107.84M | -11.47M | -33.13M | 235.04M |
| NetOtherFinancingCharges | -55.69M | -14.10M | -36.55M | -18.85M |
| ProceedsFromStockOptionExercised | 30.89M | 4.62M | 3.42M | 2.04M |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | -83.04M | -2.00M | 0.00 | 250.66M |
| CommonStockPayments | -83.04M | -2.00M | 0.00 | -22.03M |
| CommonStockIssuance | 0.00 | 0.00 | 272.69M | |
| NetIssuancePaymentsOfDebt | 0.00 | 0.00 | 1.19M | |
| NetLongTermDebtIssuance | 0.00 | 0.00 | 1.19M | |
| LongTermDebtPayments | 0.00 | 0.00 | ||
| LongTermDebtIssuance | 0.00 | 0.00 | 1.19M | |
| InvestingCashFlow | -19.05M | -12.11M | 34.70M | -156.27M |
| CashFlowFromContinuingInvestingActivities | -19.05M | -12.11M | 34.70M | -156.27M |
| NetInvestmentPurchaseAndSale | 49.10M | 14.39M | 42.41M | -104.79M |
| SaleOfInvestment | 209.66M | 171.62M | 230.10M | 161.84M |
| PurchaseOfInvestment | -160.56M | -157.24M | -187.70M | -266.63M |
| NetBusinessPurchaseAndSale | -15.40M | 0.00 | -459.00K | -46.47M |
| PurchaseOfBusiness | -15.40M | 0.00 | -459.00K | -46.47M |
| NetIntangiblesPurchaseAndSale | -11.10M | -9.27M | -4.53M | -4.17M |
| PurchaseOfIntangibles | -11.10M | -9.27M | -4.53M | -4.17M |
| NetPPEPurchaseAndSale | -41.66M | -17.22M | -2.71M | -832.00K |
| PurchaseOfPPE | -41.66M | -17.22M | -2.71M | -832.00K |
| OperatingCashFlow | 251.08M | 73.48M | -26.53M | -34.41M |
| CashFlowFromContinuingOperatingActivities | 251.08M | 73.48M | -26.53M | -34.41M |
| ChangeInWorkingCapital | 78.62M | 20.82M | -14.20M | 3.46M |
| ChangeInOtherWorkingCapital | 67.55M | 6.26M | -1.72M | 1.41M |
| ChangeInOtherCurrentLiabilities | -2.44M | -1.93M | -1.60M | -1.52M |
| ChangeInOtherCurrentAssets | -56.00K | -58.00K | 17.00K | -58.00K |
| ChangeInPayablesAndAccruedExpense | 64.68M | 23.85M | 3.45M | 10.05M |
| ChangeInAccruedExpense | 23.79M | 16.52M | 909.00K | 197.00K |
| ChangeInPayable | 40.88M | 7.32M | 2.54M | 9.85M |
| ChangeInAccountPayable | 43.71M | 7.32M | 12.72M | 9.85M |
| ChangeInPrepaidAssets | -9.49M | -6.39M | -6.33M | 3.20M |
| ChangeInInventory | -41.61M | -902.00K | -8.00M | -9.63M |
| OtherNonCashItems | 2.90M | 5.88M | 2.37M | -426.00K |
| StockBasedCompensation | 92.32M | 66.08M | 42.82M | 67.21M |
| AssetImpairmentCharge | 114.00K | 429.00K | 1.13M | 0.00 |
| AmortizationOfSecurities | -4.36M | -5.69M | 146.00K | 2.17M |
| DeferredTax | -61.65M | -13.00K | -594.00K | -3.39M |
| DeferredIncomeTax | -61.65M | -13.00K | -594.00K | -3.39M |
| DepreciationAmortizationDepletion | 17.09M | 9.52M | 7.47M | 4.08M |
| DepreciationAndAmortization | 17.09M | 9.52M | 7.47M | 4.08M |
| OperatingGainsLosses | 154.00K | |||
| GainLossOnInvestmentSecurities | 154.00K | |||
| NetIncomeFromContinuingOperations | 126.04M | -23.55M | -65.68M | -107.66M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HIMS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|